Lebrikizumab reduced exacerbations in adolescents with uncontrolled asthma and had a favorable safety profile, according to results of the ACOUSTICS study.
CU Anschutz
Fitzsimons Building
13001 East 17th Place
Aurora, CO 80045
Lebrikizumab shows promise in adolescents with uncontrolled asthma
Default sub title
minute read
by Healio | May 18, 2022
